Doxazosin (Duraten (2 mg)) is an alpha blocker, prescribed for high blood pressure and benign prostatic hyperplasia (an enlarged prostate). It relaxes the muscles around the urethra and decreases ...
An open-label, noncomparative, multicenter study was conducted. The participants were general practitioners from Spain. The patients were recruited from primary care. The health care authorities were ...
In this open-label, noncontrolled, observational surveillance study, 3684 men with BPH received 4–8 mg of controlled-release doxazosin gastrointestinal therapeutic system (GITS) for 6 months; 3283 (89 ...
Doxazosin is a racemic mixture of (−)doxazosin and (+)doxazosin that is currently used as an add-on therapy for hypertension. In this study we investigated the contribution of each enantiomer to the ...
Renal and Urology News, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...
Where does this leave us relative to the use of doxazosin in the treatment of hypertension? First, since ALLHAT was not a placebo-controlled trial, but rather an active-controlled one, the study did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results